Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06033599 · ClinicalTrials.gov registry record · Phase 3
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
A Phase 3 study of Opioid Use and Tobacco Use, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 420
- Enrollment target
- 2
- Study locations
NCT06033599 is a Phase 3 study of Opioid Use and Tobacco Use that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 420 participants, below the 148,256-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06033599, a Phase 3 study of Opioid Use and Tobacco Use, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 420 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake, and 2) evaluate patient outcomes related to the effectiveness of MORE decreasing opioid, tobacco, and other drug use.
Conditions Studied
Interventions
- OTHER MORE and MI and NRT
- OTHER MORE and No MI and NRT
- OTHER Support Group and MI and NRT
- OTHER Support Group and No MI and NRT
Study Locations (2)
New Jersey
- Rutgers Robert Wood Johnson Medical School - New Brunswick
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2023-09-05 |
| Est. Completion | 2027-06-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06033599
The ClinicalTrials.gov registry entry for NCT06033599 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 420 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 148,256-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Opioid Use appearing as the primary indexed condition, and to 4 interventions - of which MORE and MI and NRT is the first listed.
NCT06033599 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New Jersey, Utah.
Frequently Asked Questions
What is clinical trial NCT06033599 about?
NCT06033599 is a clinical study titled "Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement". The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake, and 2) evaluate patient outcomes related to the effectiveness of MORE decreasing opioid, tobacco, ...
What is the current status of trial NCT06033599?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 420 participants. The study started on 2023-09-05. Estimated completion is 2027-06-30.
What conditions does trial NCT06033599 study?
This clinical trial studies the following conditions: Opioid Use, Tobacco Use, Polysubstance Abuse.
What interventions are being tested in trial NCT06033599?
The interventions under investigation include: MORE and MI and NRT (OTHER), MORE and No MI and NRT (OTHER), Support Group and MI and NRT (OTHER), Support Group and No MI and NRT (OTHER).
Who is sponsoring clinical trial NCT06033599?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06033599 being conducted?
This trial has 2 study locations across New Jersey, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
Treating Polysubstance Use Using a Novel Digital Technology
RECRUITING · Phase 3
-
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
RECRUITING · Phase 3
-
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
-
Opioid Analgesic Reduction Study
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.